U.S. market Closed. Opens in 1 day 55 minutes

INO | Inovio Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-03-311999-03-31
Revenue832.01K10.26M1.77M7.41M4.11M30.48M42.22M35.37M40.57M10.46M13.47M4.12M9.80M6.14M9.12M2.10M4.81M3.47M5.47M1.17M80.53K189.52K4.45M5.08M8.30M
Cost of Revenue3.50M5.50M4.73M94.25M88.02MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A225.00K206.25KN/AN/AN/A1.93M1.46M1.20M
Gross Profit-2.67M4.77M-2.96M-86.83M-83.91M30.48M42.22M35.37M40.57M10.46M13.47M4.12M9.80M6.14M9.12M2.10M4.81M3.24M5.26M1.17M80.53K189.52K2.53M3.62M7.10M
Operating Expenses132.56M277.84M302.99M131.49M115.22M124.57M126.86M112.60M75.86M49.95M35.01M28.76M32.02M25.36M23.08M15.76M20.71M16.81M17.64M12.68M6.71M6.12M7.08M13.15M14.00M
Selling, General & Admin47.58M90.19M53.75M37.25M27.20M29.32M28.29M23.89M18.06M15.86M13.64M10.78M11.99M12.11M13.67M10.01M11.08M8.08M5.98M6.13M4.57M3.66M6.62M5.61M5.50M
Research & Development86.68M187.65M249.24M94.25M88.02M95.26M98.57M88.71M57.79M34.10M21.37M17.98M20.03M13.26M9.41M5.75M9.63M8.51M11.45M6.55M2.15M2.47M459.71K6.98M8.10M
Other Operating Expenses-1.70M-3.86M343.37K3.42M496.20K360.80K806.82K127.55K177.56K348.14K-45.63M1.98MN/AN/A9.28M4.67T7.55T225.00K206.25K5.60M2.07M2.28MN/A566.36K400.00K
Operating Income-135.23M-267.57M-301.22M-124.08M-111.11M-94.09M-83.64M-76.24M-34.28M-39.50M-19.54M-23.49M-21.64M-19.22M-13.96M-13.66M-15.90M-13.35M-15.51M-11.51M-6.63M-5.93M-5.58M-9.53M-6.90M
Other Expenses / Income109.31K-10.08M-2.01M-38.81M-9.70M-706.88K-4.56M2.50M3.08M3.36M-46.54M3.78M6.33M1.51M-10.50M692.84K3.42M867.07K2.44K247.56K6.63M26.87K-3.29M-597.18K2.93M
Before Tax Income-135.12M-277.65M-303.22M-162.89M-120.81M-94.80M-88.21M-73.74M-31.20M-36.14M-66.08M-19.71M-12.95M-17.71M-24.46M-13.61M-12.48M-14.48M-15.50M00-5.91M-8.87M-10.13M-6.60M
Income Tax ExpensesN/A10.01M2.16M52.20M-257.33K2.17M1.76M-4.62M-2.10M-3.72M88.12M-8.11M-16.28M-4.08M11.71M-741.85K-8.12M-867.07K6.45M-537.76K-1.99M56.78KN/A638.17K-600.00K
Net Income-135.12M-287.66M-305.38M-215.09M-120.55M-96.97M-88.21M-73.74M-29.19M-36.12M-66.03M-19.67M-15.25M-17.61M-24.41M-12.97M-11.20M-12.48M-15.30M-10.97M-4.66M-5.96M-8.87M-9.60M-6.60M
Interest Expenses1.22M1.25M1.94M8.70M7.95M346.09K4.56M139.25KN/AN/A88.17MN/A34.28KN/A10.50MN/AN/AN/A3.33MN/A20.48K5.45K-20.38K24.34K24.34K
Basic Shares Outstanding22.17M19.89M17.40M12.93M8.23M92.35M81.78M73.01M68.20M59.13M46.09M33.91M31.56M25.80M18.68M10.98M10.37M7.88M4.75M4.41M3.33M2.54M1.73M1.41M1.27M
Diluted Shares Outstanding22.17M19.89M17.40M12.93M8.23M92.54M81.92M73.21M68.37M59.41M46.09M34.13M31.56M25.80M18.68M10.98M10.37M7.88M4.75M4.41M3.33M2.54M1.73M1.41M1.27M
EBITDA-130.39M-270.90M-296.56M-149.56M-107.34M-89.80M-84.74M-74.15M-33.37M-37.93M-19.45M-22.65M-21.64M-17.11M-13.96M-11.97M-10.19M-12.43M-11.38M-10.94M-6.05M-5.28M-5.58M-8.37M-8.97M
EBITDA Margin-15,671.81%-2,639.80%-16,709.72%-2,018.02%-2,610.55%-294.61%-200.70%-209.65%-82.24%-362.70%-144.39%-549.93%-220.91%-278.48%-153.04%-570.77%-211.88%-358.53%-208.07%-937.17%-7,511.39%-2,787.69%-125.22%-164.87%-108.05%
EBIT-133.89M-276.40M-301.29M-154.19M-112.86M-94.45M-81.89M-78.22M-31.29M-39.84M110.26M-27.78M-31.50M-21.70M-2.20M-13.71M-19.32M-13.35M-5.52M-11.51M-6.63M-5.90M-8.89M-8.94M-7.18M
EBIT Margin-16,092.90%-2,693.35%-16,976.28%-2,080.47%-2,744.71%-309.86%-193.95%-221.17%-77.11%-381.04%818.72%-674.45%-321.62%-353.10%-24.07%-653.47%-401.85%-384.82%-100.89%-986.27%-8,237.11%-3,114.48%-199.57%-176.03%-86.45%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-03-311999-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙